Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
10.7M
-
Shares change
-
-1.37M
-
Total reported value, excl. options
-
$10.8M
-
Value change
-
-$1.89M
-
Number of buys
-
11
-
Number of sells
-
-16
-
Price
-
$1.01
Significant Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q3 2023
39 filings reported holding VINC - Vincerx Pharma, Inc. - Common Stock as of Q3 2023.
Vincerx Pharma, Inc. - Common Stock (VINC) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.7M shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (2.06M shares), SAGE RHINO CAPITAL LLC (1.7M shares), BANK OF AMERICA CORP /DE/ (1.45M shares), Long Focus Capital Management, LLC (1.1M shares), Rock Springs Capital Management LP (892K shares), VANGUARD GROUP INC (513K shares), ExodusPoint Capital Management, LP (390K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (385K shares), Rubric Capital Management LP (354K shares), and Point72 Asset Management, L.P. (345K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.